Document Detail

The impact of beta-blockade on mortality rates in patients with congestive heart failure.
MedLine Citation:
PMID:  10908094     Owner:  NLM     Status:  MEDLINE    
The beneficial effects of beta-adrenergic blockade on mortality rates in patients after a myocardial infarction have been clear for decades. The efficacy data are now just as apparent for patients with heart failure. Although there are many subgroups of patients in whom the mortality effects of beta-blockers are not proven, knowledge about these specific populations continues to increase. Nevertheless, more information is needed so that we can properly tailor our therapy for individual patients.
S Goldstein; S S Gottlieb
Related Documents :
16298264 - Temporary dialysis treatments for heart failure in chronic kidney disease.
9814234 - Development of an ed teaching program aimed at reducing prehospital delays for patients...
8668604 - Is there a role for digoxin in patients with systolic dysfunction?
10817174 - Does gastroscopy induce myocardial ischemia in patients with coronary heart disease?
367724 - Severe hypoxemia secondary to pulmonary embolization treated successfully with the use ...
21181014 - Glomerulonephritis in schistosomiasis mansoni: a time to reappraise.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of cardiac failure     Volume:  6     ISSN:  1071-9164     ISO Abbreviation:  J. Card. Fail.     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-11-21     Completed Date:  2000-11-21     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  9442138     Medline TA:  J Card Fail     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  15-24     Citation Subset:  IM    
Henry Ford Hospital, Cardiovascular Medicine, Detroit, Michigan 48202, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use*
Bisoprolol / therapeutic use*
Carbazoles / therapeutic use*
Heart Failure / drug therapy*,  mortality
Meta-Analysis as Topic
Metoprolol / therapeutic use*
Patient Selection
Propanolamines / therapeutic use*
Randomized Controlled Trials as Topic
Risk Factors
Survival Analysis
Treatment Outcome
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Propanolamines; 0K47UL67F2/carvedilol; 37350-58-6/Metoprolol; 66722-44-9/Bisoprolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mechanistic and clinical rationales for using beta-blockers in heart failure.
Next Document:  The role of beta-blockers in preventing sudden death in heart failure.